Welcome to the Season 3 Finale of Living Our Best with Memory Loss! In this special episode, our hosts Bob, Dennis, and SuAnne—who are all living with a memory loss diagnosis—are joined by renowned Alzheimer's researcher, Dr. Gregory Jicha.
Dr. Jicha offers a powerful and hopeful look at the latest breakthroughs in Alzheimer's prevention and treatment, including the new FDA-approved drugs Leqembi and Kisunla, which are changing the biology of the disease for the first time. He also provides an exciting update on the potential of GLP-1 agonists like Semaglutide (often used for diabetes and weight loss) and the clinical trials that could make it a new tool in the fight against memory loss.
This episode is packed with encouraging insights, but remember: this is not a substitute for medical advice. We are not doctors, and any treatment options discussed should be explored in consultation with your physician.
In this episode, we discuss:
The evolution of Alzheimer's treatment, from symptom management to disease-modifying therapies.
A closer look at the new FDA-approved drugs Leqembi and Kisunla.
The groundbreaking research into Semaglutide and its potential benefits for brain health.
Why a comprehensive, multi-faceted approach to brain health is key.
The importance of getting a specific diagnosis for the cause of your memory loss.
